- Central serous chorioretinopathy associated with low dose systemic corticosteroid treatment of Behcet's disease
-
Sungwook Cha, Kyung Jin Kim, Seongmin Kweon, Sinae Lee, Byungchul Min, Eunsung Kim, Jungwook Lee
-
Yeungnam Univ J Med. 2017;34(1):111-114. Published online June 30, 2017
-
DOI: https://doi.org/10.12701/yujm.2017.34.1.111
-
-
 Abstract
 PDF
- Central serous chorioretinopathy may induce poor eyesight and serous retinal detachment. However, its exact cause has not been well established thus far. It can be associated with systemic high-dose corticosteroid treatment mainly for young and middle-aged men and may spontaneously regress or recur after withdrawal from corticosteroid. After corticosteroid administration for Behcet's disease, it is necessary to identify any ocular symptoms. Behcet's disease can lead to the development of ocular complications, such as uveitis, hypopyon, retinal vasculitis, optic neuritis, angiogenesis, secondary cataract, and glaucoma. It is possible to diagnose any of these complications via optical coherence tomography and digital indocyanine green angiography. It is easy to neglect an ocular symptom that may appear after a low-dose corticosteroid treatment as an ocular complication in patients with Behcet's disease. Thus, we report on a case concerning high-dose corticosteroid treatment with a literature review.
- Subcutaneous tissue calcification in a patient with rheumatoid arthritis.
-
Dong Hyun Kim, Kyung Jin Kim, Sung Min Kwon, Sung Ouk Cha, Jung Ouk Lee
-
Yeungnam Univ J Med. 2016;33(2):120-124. Published online December 31, 2016
-
DOI: https://doi.org/10.12701/yujm.2016.33.2.120
-
-
Abstract
PDF
- Subcutaneous tissue calcification in rheumatic diseases usually occurs in connective tissue diseases, such as systemic lupus erythematosus, scleroderma, and dermatomyositis. Domestic cases of calcification in rheumatoid arthritis have not been reported. The mechanism of subcutaneous tissue calcification may differ depending on the cause and it can develop on all parts of the body. Calcification occurring in rheumatic diseases is a major mechanism of tissue damage caused by chronic inflammation. No standard therapy for calcification has been established; however, many studies have reported on medical and surgical treatment. We report on subcutaneous tissue calcification in a rheumatoid arthritis patient tissue calcification on both sides of the buttocks, the upper limbs, and the lower limbs.
|
E-Submission
Yeungnam University College of Medicine
